JP2001510795A - レボブピバカインとその使用 - Google Patents

レボブピバカインとその使用

Info

Publication number
JP2001510795A
JP2001510795A JP2000503831A JP2000503831A JP2001510795A JP 2001510795 A JP2001510795 A JP 2001510795A JP 2000503831 A JP2000503831 A JP 2000503831A JP 2000503831 A JP2000503831 A JP 2000503831A JP 2001510795 A JP2001510795 A JP 2001510795A
Authority
JP
Japan
Prior art keywords
levobupivacaine
surgery
bupivacaine
composition
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000503831A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001510795A5 (enExample
Inventor
ローレンス・イー・マザー
アンドリュー・ジョン・マグラシャン・リチャーズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9715462.9A external-priority patent/GB9715462D0/en
Priority claimed from GBGB9722022.2A external-priority patent/GB9722022D0/en
Priority claimed from GBGB9810427.6A external-priority patent/GB9810427D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of JP2001510795A publication Critical patent/JP2001510795A/ja
Publication of JP2001510795A5 publication Critical patent/JP2001510795A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Electrotherapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2000503831A 1997-07-22 1998-07-21 レボブピバカインとその使用 Pending JP2001510795A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9715462.9A GB9715462D0 (en) 1997-07-22 1997-07-22 levobupivacaine and its use
GB9715462.9 1997-07-22
GBGB9722022.2A GB9722022D0 (en) 1997-10-17 1997-10-17 Levobupivacaine and its use
GB9722022.2 1997-10-17
GB9810427.6 1998-05-14
GBGB9810427.6A GB9810427D0 (en) 1998-05-14 1998-05-14 Levobupivacaine and its use
PCT/GB1998/002170 WO1999004772A2 (en) 1997-07-22 1998-07-21 Use of levobupivacaine

Publications (2)

Publication Number Publication Date
JP2001510795A true JP2001510795A (ja) 2001-08-07
JP2001510795A5 JP2001510795A5 (enExample) 2006-01-05

Family

ID=27268945

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000503831A Pending JP2001510795A (ja) 1997-07-22 1998-07-21 レボブピバカインとその使用

Country Status (12)

Country Link
US (2) US6069155A (enExample)
EP (1) EP0998287B1 (enExample)
JP (1) JP2001510795A (enExample)
AT (1) ATE239474T1 (enExample)
AU (1) AU739510B2 (enExample)
BR (1) BR9802537A (enExample)
CA (1) CA2294921C (enExample)
DE (1) DE69814394T2 (enExample)
DK (1) DK0998287T3 (enExample)
ES (1) ES2198731T3 (enExample)
PT (1) PT998287E (enExample)
WO (1) WO1999004772A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376754B1 (en) * 1997-03-07 2002-04-23 Asgrow Seed Company Plants having resistance to multiple herbicides and its use
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
WO2001070322A1 (en) * 2000-03-24 2001-09-27 Stephen Brushey Anesthesia conduction catheter
US7805188B2 (en) * 2000-03-24 2010-09-28 Micor, Inc. Anesthesia conduction catheter for delivery of electrical stimulus
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
WO2002096368A2 (en) * 2001-05-31 2002-12-05 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
AU2002359407B2 (en) * 2001-11-14 2008-02-28 Durect Corporation Catheter injectable depot compositions and uses thereof
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CN1684663A (zh) 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
WO2004012703A1 (en) * 2002-07-31 2004-02-12 Alza Corporation Injectable depot compositions and uses thereof
WO2004060147A2 (en) * 2002-12-31 2004-07-22 The Board Of Trustees Of The University Of Illinois Tissue and organ preservation, protection and resuscitation
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method
CN119677554A (zh) 2022-05-05 2025-03-21 普络夫有限责任公司 麻醉神经阻滞和方法
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010276A1 (en) * 1993-10-13 1995-04-20 Chiroscience Limited Levobupivacaine useful for managing chronic pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
AU694453B2 (en) * 1993-10-13 1998-07-23 Darwin Discovery Limited Analgesic agent and its use
US5849763A (en) * 1993-10-13 1998-12-15 Darwin Discovery Limited Use of levobupivacaine as an anesthetic agent
CA2216583C (en) * 1995-04-13 2007-10-30 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women
GB9704352D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010276A1 (en) * 1993-10-13 1995-04-20 Chiroscience Limited Levobupivacaine useful for managing chronic pain

Also Published As

Publication number Publication date
DE69814394T2 (de) 2004-03-11
PT998287E (pt) 2003-09-30
ES2198731T3 (es) 2004-02-01
US6514994B2 (en) 2003-02-04
EP0998287B1 (en) 2003-05-07
DK0998287T3 (da) 2003-09-01
AU8452898A (en) 1999-02-16
AU739510B2 (en) 2001-10-11
EP0998287A2 (en) 2000-05-10
US6069155A (en) 2000-05-30
US20020016338A1 (en) 2002-02-07
CA2294921A1 (en) 1999-02-04
WO1999004772A2 (en) 1999-02-04
WO1999004772A3 (en) 1999-04-08
DE69814394D1 (de) 2003-06-12
CA2294921C (en) 2009-04-07
ATE239474T1 (de) 2003-05-15
BR9802537A (pt) 1999-07-20

Similar Documents

Publication Publication Date Title
EP0998287B1 (en) Use of levobupivacaine
US5849763A (en) Use of levobupivacaine as an anesthetic agent
EP0727210B1 (en) Analgesic agent and its use
Gristwood et al. Levobupivacaine: a new safer long acting local anaesthetic agent
KR100516676B1 (ko) 안면 수술에서의 레보부피바카인의 용도
JP2001510794A (ja) レボブピバカインとその使用
CA2216583C (en) Levobupivacaine and its use as an anaesthetic in pregnant women
JP2001515479A (ja) 偏頭痛治療におけるレボブピバカインまたはロピバカインの使用
WO1998038997A1 (en) Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
MXPA00000396A (en) Levobupivacaine and its use
Haque et al. The Clinical Efficacy of Hyperbaric Solution of Ropivacaine (0.5%) With Hyperbaric Bupivacaine (0.5%) in Spinal Anaesthesia
Rowe et al. Heart block during abdominal surgery in a child
Abd El Moeti et al. Ropivacaine versus Bupivacaine for Inter Scalene Block Clinical and Pharmacological Comparative Study
Dube A Comparative, Randomized, Open Labelled Study of the Clinical Efficacy and Safety of Intrathecal Levobupivacaine and Bupivacaine in Lower Limb Surgeries at a Tertiary Care Centre
Gupta et al. Comparative evaluation of a mixture of atracarium and tramadol or ketorolac as an adjunct to low dose lignocaine in intravenous regional anesthesia
Brown et al. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
Nazlikul et al. History, Pharmacology und Toxicity of Localanesthetics
EP0450232A2 (en) P-Guanidino benzoic acid derivatives for treatment of cerebrovascular contraction
HU210322B (en) Process for production of preparations containing ropivacaine for treatment of iontophoresis
MXPA99008056A (en) The use of levobupivacaine or ropivacaine in treating migraine

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050712

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050712

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090331

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090630

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090707

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090729

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090915

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120627